AF

Ann Fandel

Executive Assistant to the Chief Scientific Officer - Research

Intellia Therapeutics, Inc.

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Intellia Therapeutics, Inc.
Industry
research
Employees
470.0
Seniority
C suite
Annual Revenue
57877000.0

Professional Summary

Ann Fandel serves as Executive Assistant to the Chief Scientific Officer - Research at Intellia Therapeutics, Inc.. Intellia Therapeutics, Inc. operates in the research sector with approximately 470.0 employees. The company is headquartered in Cambridge, Massachusetts. Intellia Therapeutics, Inc. generates annual revenue of 57877000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • 3,781 executive contacts are available in Massachusetts.
  • Our database includes 201,469 c suite-level executives.

Technologies

DNS Made Easy Mimecast Microsoft Office 365 Drupal WP Engine Adobe Marketing Cloud Google Tag Manager Gravity Forms WordPress.org Akamai RUM Mobile Friendly Hotjar New Relic Vimeo Circle Remote AI

Keywords

biotechnology life sciences biotechnology: in vitro & in vivo diagnostic substances health care biotechnology research crispr gene editing genome editing clinical trials therapeutics disease treatment potentially curative ex vivo in vivo genetic diseases autoimmune diseases hematological malignancies solid tumors lipid nanoparticles engineered cell therapies patient stories scientific publications research collaboration nobel prize genetic engineering translational medicine cell therapy oncology safety efficacy precision medicine medical history patient focus genetic correction disease progression disease severity biopharmaceutical patient advocacy rare diseases immunology gene therapy pharmaceuticals regulatory approvals novel therapeutics biologic therapies dna modification genetic modification therapeutic strategies clinical development next-generation therapies research & development biotech innovations medical treatments immuno-oncology liver diseases hereditary angioedema transthyretin amyloidosis alpha-1 antitrypsin deficiency clinical-stage in vivo therapies ex vivo therapies rare genetic disorders transformative therapies partnerships collaborations patient-centric innovative treatments curative therapies healthcare providers biotechnology partnerships market opportunities unmet medical needs strategic focus modular platform hemophilia patient outcomes therapeutic programs pipeline development health wellness & fitness hospital & health care medical

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Ann Fandel?

Ann Fandel's verified email address is available on MessageCEO. They currently work at Intellia Therapeutics, Inc.. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Ann Fandel lead?

Ann Fandel is Executive Assistant to the Chief Scientific Officer - Research at Intellia Therapeutics, Inc., a company in the research sector with 470.0 employees. The company is based in Cambridge, Massachusetts.

What industry is Ann Fandel in?

Ann Fandel works in the research industry as Executive Assistant to the Chief Scientific Officer - Research at Intellia Therapeutics, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Ann Fandel's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ann Fandel's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 7, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans